Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
While these compounds have been studied for antioxidant activity in laboratory settings, robust clinical evidence specifically supporting skin benefits in humans is limited
Recent studies have observed that cepharanthine is capable of inhibiting the interaction between TSHR.132 (TSH receptor peptide) and HLA-DR1-Arg74, thus blocking T cell activation and cytokine response in a Graves disease-relevant humanized mouse model expressing HLA-DR3 (Li et al
M.ComptonK.DeanF
Cureus Journal of Medical Science You can unsubscribe anytime
[Abstract]2025 Mar 28;23(4):146
US$ 29.87
:format(webp))
US$ 29.67
US$ 27.59
US$ 20.00
US$ 19.98
